218 related articles for article (PubMed ID: 32458297)
1. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".
Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q
Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297
[TBL] [Abstract][Full Text] [Related]
2. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
[TBL] [Abstract][Full Text] [Related]
3. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
[TBL] [Abstract][Full Text] [Related]
4. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of a replication-competent human adenovirus type 3-based vector as a live-vaccine candidate and a viral delivery vector.
Zhang Q; Su X; Seto D; Zheng BJ; Tian X; Sheng H; Li H; Wang Y; Zhou R
Vaccine; 2009 Feb; 27(8):1145-53. PubMed ID: 19146906
[TBL] [Abstract][Full Text] [Related]
6. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
[TBL] [Abstract][Full Text] [Related]
7. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections.
Panda S; Banik U; Adhikary AK
Infect Genet Evol; 2020 Nov; 85():104439. PubMed ID: 32585339
[TBL] [Abstract][Full Text] [Related]
9. A recombinant replication-defective human adenovirus type 3: a vaccine candidate.
Li H; Zhou R; Chen J; Tian X; Zhang Q; Zeng Q; Gong S
Vaccine; 2009 Jan; 27(1):116-22. PubMed ID: 18977265
[TBL] [Abstract][Full Text] [Related]
10. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
[TBL] [Abstract][Full Text] [Related]
11. Rapid Construction of a Replication-Competent Infectious Clone of Human Adenovirus Type 14 by Gibson Assembly.
Pan H; Yan Y; Zhang J; Zhao S; Feng L; Ou J; Cao N; Li M; Zhao W; Wan C; Ismail AM; Rajaiya J; Chodosh J; Zhang Q
Viruses; 2018 Oct; 10(10):. PubMed ID: 30340336
[TBL] [Abstract][Full Text] [Related]
12. Bivalent vaccine platform based on ca influenza virus vaccine elicits protective immunity against human adenoviruses.
Gu H; Gao Y; Zhou S; Sun F; Zhao Z; Wang K; Zhao L; Zhang P; Wang Z; Zhang S; Wang X; Yang P
Antiviral Res; 2018 May; 153():78-84. PubMed ID: 29501624
[TBL] [Abstract][Full Text] [Related]
13. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
[TBL] [Abstract][Full Text] [Related]
14. Development of monoclonal antibodies targeting the conserved fragment of hexon protein to detect different serotypes of human adenovirus.
Wu L; Lin Y; Yin J; Yang C; Jiang Y; Zhai L; Wang Y; Zhu L; Wu Q; Zhang B; Wan C; Zhao W; Yang Y; Shen C; Xiao W
Microbiol Spectr; 2024 Apr; 12(4):e0181623. PubMed ID: 38385650
[TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
[TBL] [Abstract][Full Text] [Related]
16. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the Prevalence of Binding and Neutralizing Antibodies against 39 Human Adenovirus Types in Student Cohorts Reveals Low-Prevalence Types and a Decline in Binding Antibody Levels during the SARS-CoV-2 Pandemic.
Wang X; Kerkmann L; Hetzel M; Windmann S; Trilling M; Zhang W; Ehrhardt A; Bayer W
J Virol; 2022 Nov; 96(22):e0113322. PubMed ID: 36342295
[TBL] [Abstract][Full Text] [Related]
18. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.
Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z
Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
Duffy MR; Alonso-Padilla J; John L; Chandra N; Khan S; Ballmann MZ; Lipiec A; Heemskerk E; Custers J; Arnberg N; Havenga M; Baker AH; Lemckert A
J Gen Virol; 2018 Jan; 99(1):135-147. PubMed ID: 29154744
[TBL] [Abstract][Full Text] [Related]
20. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
